Michael Gelband’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,350
Closed -$3.97M 1984
2026
Q1
$3.97M Buy
+13,350
New +$3.87M 0.03% 508
2025
Q2
Sell
-12,320
Closed -$2.96M 1906
2025
Q1
$2.96M Buy
+12,320
New +$2.98M 0.03% 568
2024
Q4
Sell
-17,588
Closed -$4.79M 1966
2024
Q3
$4.79M Buy
+17,588
New +$4.24M 0.03% 439
2023
Q3
Sell
-10,916
Closed -$2.04M 2071
2023
Q2
$2.04M Sell
10,916
-4,217
-28% -$839K 0.02% 796
2023
Q1
$3.03M Buy
+15,133
New +$3.05M 0.03% 716
2022
Q4
Sell
-5,006
Closed -$703K 2053
2022
Q3
$703K Sell
5,006
-7,559
-60% -$1.05M 0.01% 1247
2022
Q2
$1.97M Sell
12,565
-20,605
-62% -$3.12M 0.02% 787
2022
Q1
$5.26M Buy
33,170
+31,847
+2,407% +$4.95M 0.07% 375
2021
Q4
$224K Sell
1,323
-11,525
-90% -$1.81M ﹤0.01% 1785
2021
Q3
$1.79M Buy
+12,848
New +$1.95M 0.02% 769
2021
Q2
Sell
-7,315
Closed -$1.17M 2733
2021
Q1
$1.17M Buy
7,315
+5,322
+267% +$860K 0.02% 820
2020
Q4
$330K Sell
1,993
-92,946
-98% -$15.8M ﹤0.01% 1493
2020
Q3
$16.1M Buy
94,939
+87,486
+1,174% +$15.5M 0.32% 41
2020
Q2
$1.27M Buy
7,453
+4,917
+194% +$807K 0.03% 618
2020
Q1
$379K Buy
+2,536
New +$451K 0.02% 581

Other funds holding RNR

Michael Gelband's RNR Position: Q2 2026 in Review

Michael Gelband sold out of RenaissanceRe (RNR) in Q2 2026, closing a stake of 13,350 shares — an estimated $3.97M sold.

Michael Gelband first reported a position in RNR in Q1 2020 and held it in 15 quarters. The position peaked at $16.1M in Q3 2020. 570 funds tracked by Wall St. Rank hold RNR as of Q2 2026.

  • Michael Gelband reported no remaining RenaissanceRe position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 13,350 RenaissanceRe shares in Q2 2026, an estimated $3.97M.
  • Michael Gelband first reported a position in RenaissanceRe in Q1 2020 and held it in 15 quarters.
  • Michael Gelband's RenaissanceRe position peaked at $16.1M in Q3 2020.
  • 570 funds tracked by Wall St. Rank held RenaissanceRe as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.